AI English summary of an SEC filing — figures as filed
The company entered into an underwriting agreement with BofA Securities, Goldman Sachs, J.P. Morgan Securities and Wells Fargo Securities to sell 4.800% Senior Notes due 2029 with an aggregate principal amount of $400.0 million, dated January 9, 2024.
Key points
AI summaryThe company entered into an underwriting agreement with BofA Securities, Goldman Sachs, J.P. Morgan Securities and Wells Fargo Securities to sell 4.800% Senior Notes due 2029 with an aggregate principal amount of $400.0 million, dated January 9, 2024.
The company said the Notes are being offered at 99.889% of their principal amount, and the underwriters' purchase of the Notes is scheduled to close on January 11, 2024, subject to customary closing conditions.
The company said it plans to use the net proceeds from the offering for general corporate purposes, including working capital, funding capital expenditures, repaying indebtedness and other business opportunities.
The company filed a Prospectus dated November 10, 2022 and a Prospectus Supplement dated January 9, 2024 under its Form S-3 registration statement, and filed as Exhibit 5.1 a legal opinion from McDermott Will & Emery LLP dated January 10, 2024.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
$400.0 million 4.800% Senior Notes due 2029 Underwriting Agreement
The company entered into an underwriting agreement with BofA Securities, Goldman Sachs, J.P. Morgan Securities and Wells Fargo Securities to sell 4.800% Senior Notes due 2029 with an aggregate principal amount of $400.0 million, dated January 9, 2024.
Source · Based on the filing body and exhibits
Notes priced at 99.889%, closing expected on January 11, 2024
The company said the Notes are being offered at 99.889% of their principal amount, and the underwriters' purchase of the Notes is scheduled to close on January 11, 2024, subject to customary closing conditions.
Source · Based on the filing body and exhibits
Use of Net Proceeds
The company said it plans to use the net proceeds from the offering for general corporate purposes, including working capital, funding capital expenditures, repaying indebtedness and other business opportunities.
Source · Based on the filing body and exhibits
Filing of Form S-3 Registration Statement and Exhibit 5.1 Legal Opinion
The company filed a Prospectus dated November 10, 2022 and a Prospectus Supplement dated January 9, 2024 under its Form S-3 registration statement, and filed as Exhibit 5.1 a legal opinion from McDermott Will & Emery LLP dated January 10, 2024.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…